Sage Journals: Discover world-class research

Open access

Research article

First published 2024-03

A Systematic Review of Treatment-Related Adverse Events for Combination Therapy of Multiple Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor

Takashi Sawada, Mamoru Narukawa

Cancer Control

Open access

Review article

First published 2024

A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis

Laura Airas, Robert A. Bermel, Tanuja Chitnis [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2023-10

Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor

Amit Bar-Or, Anne H Cross, Anthony L Cunningham [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2010-10

Quantitative Structure–Activity Relationship Analysis of 4(3H)-Quinazolone Derivatives as Tyrosine Kinase Inhibitors by Multiple Linear Regression

Vikas Srivastava, Deepa Sinha, Anjani K. Tiwari [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Article commentary

First published 2020-7

Optimizing patient selection for treatment-free remission

Caitlin R Rausch, Shilpa Paul

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2020-9

Development of a quality measures tool for the utilization of tyrosine kinase inhibitors in non-small cell lung cancer: An integrated specialty pharmacy initiative

Garrett Crothers, Nisha B Shah, Moonjung Kim [...]

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2019-5

Testicular metastasis from renal cell carcinoma after nephrectomy and on tyrosine kinase inhibitors therapy: Case report and review

Alberto De Gobbi, Mario Salvatore Mangano, Giandavide Cova [...]

Urologia Journal

Retricted access

Case report

First published 2019-4

Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib

David J Hermel, Victor Chiu, Melody H Hermel [...]

Journal of Oncology Pharmacy Practice

Free access

Research article

First published 2010-5

A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma

Craig W. Menges, Yibai Chen, Brooke T. Mossman [...]

Genes & Cancer

Open access

Research article

First published 2024-4

Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study

Xavier Montalban, Karolina Piasecka-Stryczynska, Jens Kuhle [...]

Multiple Sclerosis Journal

Search results